上海复旦张江生物医药股份有限公司于2026年2月24日披露2026年1月股份变动月报表，显示截至1月31日，公司已发行H股（01349）总数维持在326,000,000股，A股（上海证券交易所科创板：688505）总数继续保持710,572,100股，均与上月底持平。
公司注册股本持续为人民币103,657,210元，其中H股注册股本人民币32,600,000元，A股注册股本人民币71,057,210元。报告期内未发生新增发行、购回、注销或库存股变动，也无股份期权和股权激励计划的进展披露。
公司同时确认，截至1月底符合香港联交所有关最低公众持股量的要求。公告由公司秘书薛燕签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.